NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1031 coverVITAMIN E AND HEALTH Volume 1031 published December 2004
Ann. N.Y. Acad. Sci. 1031: 242–248 (2004). doi: 10.1196/annals.1331.024
Copyright © 2004 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by POSTON, L.
Articles by KELLY, F.
Search for Related Content
PubMed
PubMed Citation
Articles by POSTON, L.
Articles by KELLY, F.
Vitamin E in Preeclampsia

LUCILLA POSTONa, MAARTEN RAIJMAKERSa AND FRANK KELLYb

aMaternal and Fetal Research Unit, Division of Reproductive Health, Endocrinology and Development, King's College Hospital, St. Thomas' Hospital, London SE1 7EH, United Kingdom
bSchool of Health and Life Sciences, King's College, London SE1 9NN, United Kingdom

Address for correspondence: Professor Lucilla Poston, MFRU, Division of Reproductive Health, Endocrinology and Development, St.Thomas' Hospital, 10th Floor, North Wing, Lambeth Palace Road, London SE1 7EH, United Kingdom. Voice: (44) 207 188 3644; fax: (44) 207 620 1227. lucilla.poston{at}kcl.ac.uk

Preeclampsia is the disorder of pregnancy with the highest rate of both maternal and neonatal morbidity and mortality. The maternal syndrome is characterized by oxidative stress and activation of the vascular endothelium that may originate from placental release of lipid peroxidation products, cytokines, and microparticles leading to an acute inflammatory response. The current understanding of the etiology has allowed the improvement of predictive tests, tests that could make intervention possible from early pregnancy onwards. Although the large secondary intervention antioxidant trials in cardiovascular diseases did not show any beneficial effect of vitamin E and vitamin C, either alone or in combination, knowledge of the nature of the pathogenesis of preeclampsia offers hope for the beneficial use of antioxidants in the prevention of the disorder. Not only has our previous small trial shown that antioxidant prophylactics in high-risk women lowered the prevalence of preeclampsia, but also new evidence has demonstrated multiple other actions of {alpha}-tocopherol (such as anti-inflammation and inhibition of NAD(P)H oxidase activation) besides its antioxidant properties that could be advantageous in the prevention of the disorder. Several larger trials are under way to investigate the precise role that vitamins C and E can play in the prevention of preeclampsia.

Key Words: vitamin E • vitamin C • preeclampsia




This article has been cited by other articles:


Home page
Diabetes CareHome page
T. M. Paravicini and R. M. Touyz
NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180.
[Abstract] [Full Text] [PDF]



footerLeft footerRight